Estimaciones de analistas de Wall Street para Nuwellis, Inc. (NUWE): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 1 |
| Mantener | 1 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 2 |
| Calificación media (1-5) | 0.50 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-13.65 | ||
| 2026-08-13 | $-26.64 | $-23.80 | -11.9% |
| 2026-05-12 | $-0.73 | $-0.35 | -109.0% |
| 2026-03-10 | $-0.52 | $-0.55 | +3.9% |
| 2025-11-12 | $19.58 | $-602.70 | +103.2% |
| 2025-08-14 | $-21.35 | $-6.62 | -222.7% |
| 2025-05-13 | $-10.14 | $-6.61 | -53.3% |
| 2025-03-11 | $-9.55 | $-0.21 | -4524.4% |
Ratios de valoración
| Precio / Valor contable | -0.07 |
| EV / EBITDA | 0.50 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.3M | $3.6M | $5.0M | $5.5M | $7.4M | $7.9M | $8.5M | $8.9M | $8.7M | $8.3M |
| Coste de Ventas | $713000 | $2.8M | $3.7M | $2.7M | $3.4M | $3.4M | $3.8M | $3.9M | $2.9M | $3.1M |
| Beneficio Bruto | $576000 | $790000 | $1.3M | $2.9M | $4.1M | $4.5M | $4.8M | $5.0M | $5.8M | $5.1M |
| I+D | $8.1M | $1.5M | $3.1M | $4.7M | $3.7M | $5.0M | $4.3M | $5.4M | $3.2M | $2.7M |
| Generales y Administrativos | $8.1M | $10.2M | $15.3M | $16.3M | $17.4M | $19.0M | $17.6M | $17.2M | 0 | $13.5M |
| Gastos Operativos | $16.2M | $11.7M | $18.4M | $21.0M | $21.1M | $24.0M | $21.9M | $22.6M | $16.8M | $16.2M |
| Beneficio Operativo | -$15.7M | -$14.8M | -$17.0M | -$18.1M | -$17.0M | -$19.5M | -$17.2M | -$17.6M | -$11.0M | -$11.1M |
| EBITDA | -$14.6M | -$10.1M | -$16.8M | -$17.9M | -$16.7M | -$19.1M | -$4.9M | -$16.4M | -$10.5M | -$6.5M |
| Gastos por Intereses | $504000 | $2.5M | 0 | 0 | 0 | 0 | $9.2M | $3.5M | $5.6M | $10.6M |
| Beneficio Antes de Impuestos | -$15.8M | -$13.4M | -$17.0M | -$18.1M | -$15.8M | -$19.5M | -$14.5M | -$20.2M | -$11.2M | -$17.5M |
| Impuestos | -$54000 | $6000 | $6000 | $8000 | $9000 | $9000 | $9000 | $8000 | $5000 | $5000 |
| Beneficio Neto | -$15.8M | -$13.4M | -$17.0M | -$18.1M | -$15.8M | -$19.6M | -$14.5M | -$20.2M | -$11.2M | -$17.5M |
| BPA | $-184240000.00 | $-156123333.45 | $-149030000.00 | $-14408863.70 | $-709679.95 | $-350143.15 | $-102268.25 | $-12602.45 | $-280.00 | $-25.39 |
| BPA Diluido | $-184240000.00 | $-156123333.45 | $-149030000.00 | $-14408863.70 | $-709679.95 | $-350143.15 | $-102268.25 | $-12602.45 | $-280.00 | $-25.39 |
| Acciones en Circulación (Diluidas) | $0 | $0 | $0 | $1 | $22 | $56 | $142 | $1604 | $37921 | $197184 |
Precio
| Precio | $0.81 |
| Capitalización | $0M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ACON · BACK · BCTXW · IVF · NUVO · OCEA · PETV
Explorar sector: Healthcare · Medical - Devices
Más secciones de NUWE: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones